ESCRS - POCAT156 - Toxic Anterior Segment Syndrome With Intracameral Moxifloxacin

Toxic Anterior Segment Syndrome With Intracameral Moxifloxacin

Published 2026 - 44th Congress of the ESCRS

Reference: POCAT156 | Type: Poster | DOI: 10.82333/tqt2-1r73

Authors: Dr Hazem Elnashar* 1

1Ophthalmology,The Memorial Institute for Ophthalmic Research,Giza,Egypt

Purpose

to show that high dose of intracameral moxifloxacin can cause TASS even if it is preservative free

Setting

The memorial institute for ophthalmic research (MIOR)

Methods

A 60 y old female c/o of drop of vision in left eye .   patient underwent routine phaco and single-piece acrylic
IOL, Intracameral preservative-free moxifloxacin was used at the end of the case ( total volume  was  0.5 cc ).  1st day
post –op I found  sever inflammation , the fluid in the eye was dark , aggressive membranes in AC and around IOL ,
vision was HM  mild pain, no chemosis . U/S  showed completely free post seg. So I decided  to fu without interference . I
found the same pic in the 2nd day so I diagnosed the patient as TASS and I decided to do AC wash and started to review
literature about the causes of TASS  and I found that  Intracameral Moxifloxacin can cause this .the patient continued on
very high doses of topical steroids

Results

The patient started to improve and to took about 4 months until complete resolve of ant seg occurred leaving
large areas of iris depigmentation , very week pupillary reaction , dense PCO and high IOP . I continued on anti glaucoma
until IOP controlled and did YAG capsulotomy  and the final UCVA reached 0.6 that improve by glasses to 0.9

Conclusions

High dose of intracameral moxifloxacin can cause TASS even if it is preservative free
We should differentiate between endophthmitis and TASS